| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1371954 | Bioorganic & Medicinal Chemistry Letters | 2006 | 6 Pages |
Metacaspase (MCA) is an important enzyme in Trypanosoma brucei, absent from humans and differing significantly from the orthologous human caspases. Therefore MCA constitutes a new attractive drug target for antiparasitic chemotherapeutics, which needs further characterization to support the discovery of innovative drug candidates. A first series of inhibitors has been prepared on the basis of known substrate specificity and the predicted catalytic mechanism of the enzyme. In this Letter we present the first inhibitors of TbMCA2 with low micromolar enzymatic and antiparasitic activity in vitro combined with low cytotoxicity.
Graphical abstractWe present the first inhibitors of metacaspase 2 of Trypanosoma brucei with low micromolar enzymatic activity. These compounds possess modest antiparasitic activity and have excellent selectivity when compared to mammalian caspases.Figure optionsDownload full-size imageDownload as PowerPoint slide
